Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, May 12, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
USFDA Authorizes Marketing of the First Cardiac Ultrasound Software That Uses Artificial Intelligence to Guide User
admin
-
February 8, 2020
0
Latest Pharma-News
Sanofi brain-penetrant BTK (Bruton’s tyrosine kinase) inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis
admin
-
February 8, 2020
0
Latest Pharma-News
Aquestive Therapeutics Announces FDA Confirmed 505(b)(2) Pathway for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment
admin
-
February 7, 2020
0
Latest Pharma-News
FDA Moves Closer to the Standardized Testing for Asbestos in Talc
admin
-
February 7, 2020
0
Latest Pharma-News
VIVUS Receives U.S. FDA Approval for the Improved Formulation of PANCREAZE® with a 36-Month Shelf Life
admin
-
February 7, 2020
0
Latest Pharma-News
U.S.FDA approves Alector’s Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia
admin
-
February 7, 2020
0
Latest Pharma-News
BioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501 (dexmedetomidine)for the Treatment of Opioid Withdrawal Symptoms
admin
-
February 7, 2020
0
Latest Pharma-News
MorphoSys Initiates Expanded Access Program for Tafasitamab (anti-CD19 antibody) in the U.S.
admin
-
February 6, 2020
0
Latest Pharma-News
CEPI and GSK announce new collaboration to strengthen the global effort to develop a vaccine for the coronavirus (2019-nCoV virus)
admin
-
February 6, 2020
0
Latest Pharma-News
GRADUATE PHARMACY APTITUDE TEST (GPAT): GPAT Result 2020
admin
-
February 5, 2020
0
Latest Pharma-News
Vituro Health Successfully Completes First three TULSA-PRO® treatments to ablate prostate tissue in the United States Following FDA 510(K) Clearance
admin
-
February 5, 2020
0
Latest Pharma-News
Accumen’s 3DR Labs Partners with Resonance Health to develop its MRI Analysis Services
admin
-
February 5, 2020
0
1
...
129
130
131
...
144
Page 130 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024